During the past decade, CCR, Czech a.s. conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 15 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 12 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCR, Czech a.s." #1 sponsor was "Pfizer" with 7 trials, followed by "Galapagos NV" with 3 trials sponsored, "R-Pharm International, LLC" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Nordic Bioscience A/S" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCR, Czech a.s." #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Novartis" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "IQVIA Pvt. Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "CCR, Czech a.s." are "Psoriatic Arthritis" (4 trials), "Rheumatoid Arthritis" (4 trials), "Ankylosing Spondylitis" (2 trials), "Cardiovascular Disease" (2 trials) and "Dermatitis, Atopic" (2 trials). Many other conditions were trialed in "CCR, Czech a.s." in a lesser frequency.

Most popular intervention types in "CCR, Czech a.s." are "Drug" (26 trials), "Biological" (3 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "filgotinib" (3 trials), "Placebo Oral Tablet" (2 trials), "Spesolimab" (2 trials) and "Vehicle" (2 trials). Other intervention names were less common.

The vast majority of trials in "CCR, Czech a.s." are 28 trials for "All" genders.

Currently, there are NaN active trials in "CCR, Czech a.s.". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in CCR, Czech a.s., undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in CCR, Czech a.s., 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".